-
Alexander Cole, PhD,
Magee-Womens Research Institute
Mentored Investigator Grant
Investigating Regulators of Quiescence in Epithelial Ovarian Cancer
-
Sarah Gitto, PhD,
University of Pennsylvania
Mentored Investigator Grant
Modeling Autologous TIL Therapy in Novel PARP Resistant PDX Model for Ovarian Cancer
-
Guy Katz, MD, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Therapeutic miRNA Targeting for Ovarian Cancer
-
Isaac Klein, MD, PhD,
Dana Farber Cancer Institute
Mentored Investigator Grant
Transcriptional Regulatory Landscape of High Grade Serous Ovarian Cancer
-
John Krais, PhD,
Fox Chase Cancer Center
Mentored Investigator Grant
Examining the Role of RNF168 in BRCA1 Mutant Ovarian Cancer
-
Marilyne Labrie, PhD,
Oregon Health and Science University
Mentored Investigator Grant
Synergistic Lethality of PARP and P13K Pathway Inhibitors in Ovarian Cancer
-
Jing Li, MD, PhD,
University of Michigan
Mentored Investigator Grant
ARID1A Drives Ovarian Cancer Immunotherapy
-
Shariska Petersen, MD,
University of Kansas Medical Center Research Institute
Mentored Investigator Grant
Cyclin E and BRD4 as Markers for a New PARPi Drug Combination
-
Alba Rodriguez-Garcia, PhD,
University of Pennsylvania
Mentored Investigator Grant
Targeting MISIIR with CAR T Cells for the Treatment of Ovarian Cancer
-
Elaine Stur, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Re-activating Anti-tumor Immunity Targeting PSEN1 in CAFS in Ovarian Cancer
-
Shuai Wu, PhD,
The Wistar Institute
Mentored Investigator Grant
Synthetic Lethality for ARID1A Mutation in Ovarian Cancer
-
Min Soon Cho, PhD,
MD Anderson Cancer Center
Early Career Investigator Grant
The Role of Platelet in the Regulation of Immune Response to Ovarian Cancer